0000000000771033

AUTHOR

Andrea Schütz

showing 2 related works from this author

Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial.

2016

AdultMalemedicine.medical_specialtyUrticariaImmunologyTreatment outcomePlacebo-controlled studyMEDLINEDrug ResistanceHistamine AntagonistsOmalizumabOmalizumablaw.invention030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineRandomized controlled trialDouble-Blind MethodlawInternal medicineAnti-Allergic AgentsImmunology and AllergyMedicineHumansbusiness.industryMiddle AgedSymptomatic dermographismTreatment Outcome030228 respiratory systemMulticenter studyFemalebusinessmedicine.drugThe Journal of allergy and clinical immunology
researchProduct

Omalizumab is effective in cold urticaria—results of a randomized placebo-controlled trial

2016

AdultMalemedicine.medical_specialtyUrticariaImmunologyTreatment outcomePlacebo-controlled studyMEDLINEOmalizumabOmalizumabCold urticarialaw.invention030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDouble-Blind MethodRandomized controlled triallawInternal medicineAnti-Allergic AgentsmedicineHumansImmunology and Allergybusiness.industryMiddle Agedmedicine.diseaseCold TemperatureTreatment Outcome030228 respiratory systemMulticenter studyPhysical therapyFemalebusinessmedicine.drugJournal of Allergy and Clinical Immunology
researchProduct